Home
Sign In
About
Curriculum
Activity Information
Target Audience
Learning Objectives
Technical Requirements
The Curriculum in Iron Metabolism & Related Disorders is supported by an educational grant from
Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.
Course materials have been developed for use outside of the United States.
|
 |
|
|
|
|
|
Case 1 |
Case 2 |
Case 3 |
Case 4
|
Iron Overload Case Library, Case 4: Rash and Low T2* in a Paediatric Thalassaemia Patient
Management of paediatric patients with iron overload poses special challenges. In this case of a paediatric thalassaemia patient, deciding which iron chelation agent to use, determining the correct starting and maintenance dosages, and dealing effectively with side effects were crucial in achieving optimal outcome with reduced cardiac iron burden.
|
|
Faculty
|
|
|
Ali T. Taher, MD
Professor
Department of Internal Medicine
American University of Beirut Medical Center
Beirut, Lebanon
|
|
|
Target Audience
This activity is designed for haematologists, medical oncologists, haematology-oncology specialists, and other healthcare professionals involved in the screening, evaluation, treatment, and management of adults and children with iron overload, resulting from the spectrum of chronic iron overload diseases.
|
Learning Objectives
After participating in this activity, participants should be better able to:
- Utilize appropriate dosage adjustments for paediatric thalassaemia patients to manage iron chelation treatment-related skin rash and reduce cardiac iron burden as measured by T2*.
|
Disclosure Information
Ali T. Taher, MD, is on the speakers bureau of and on the advisory board for Novartis Pharmaceuticals Corporation.
|
|
|
|
|
|
|
